全文获取类型
收费全文 | 37353篇 |
免费 | 1795篇 |
国内免费 | 195篇 |
专业分类
耳鼻咽喉 | 451篇 |
儿科学 | 852篇 |
妇产科学 | 369篇 |
基础医学 | 4904篇 |
口腔科学 | 947篇 |
临床医学 | 2650篇 |
内科学 | 9008篇 |
皮肤病学 | 646篇 |
神经病学 | 2962篇 |
特种医学 | 1406篇 |
外科学 | 5895篇 |
综合类 | 217篇 |
一般理论 | 1篇 |
预防医学 | 1308篇 |
眼科学 | 577篇 |
药学 | 3146篇 |
中国医学 | 90篇 |
肿瘤学 | 3914篇 |
出版年
2023年 | 186篇 |
2022年 | 382篇 |
2021年 | 667篇 |
2020年 | 350篇 |
2019年 | 482篇 |
2018年 | 619篇 |
2017年 | 522篇 |
2016年 | 599篇 |
2015年 | 623篇 |
2014年 | 857篇 |
2013年 | 1065篇 |
2012年 | 1589篇 |
2011年 | 1777篇 |
2010年 | 1052篇 |
2009年 | 934篇 |
2008年 | 1579篇 |
2007年 | 1642篇 |
2006年 | 1676篇 |
2005年 | 1816篇 |
2004年 | 1746篇 |
2003年 | 1719篇 |
2002年 | 1700篇 |
2001年 | 1268篇 |
2000年 | 1402篇 |
1999年 | 1243篇 |
1998年 | 505篇 |
1997年 | 386篇 |
1996年 | 378篇 |
1995年 | 340篇 |
1994年 | 314篇 |
1993年 | 315篇 |
1992年 | 840篇 |
1991年 | 746篇 |
1990年 | 765篇 |
1989年 | 823篇 |
1988年 | 750篇 |
1987年 | 653篇 |
1986年 | 627篇 |
1985年 | 590篇 |
1984年 | 476篇 |
1983年 | 349篇 |
1982年 | 214篇 |
1981年 | 162篇 |
1980年 | 168篇 |
1979年 | 294篇 |
1978年 | 240篇 |
1977年 | 181篇 |
1974年 | 166篇 |
1971年 | 154篇 |
1969年 | 173篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Shinji Naganawa Rintaro Ito Hisashi Kawai Toshiaki Taoka Tadao Yoshida Michihiko Sone 《Magnetic resonance in medical sciences》2020,19(4):375
Purpose:It has been reported previously that intravenously administered gadolinium-based contrast agent (GBCA) leaks into the subarachnoid space around the cortical veins at 4 h after injection in all old people over 37 years, but not in younger people up to 37 years of age in 3D-real IR images. The purpose of this study was to investigate whether there was a strict threshold of 37 years of age for the leakage of the GBCA into the subarachnoid space.Methods:The subjects included 190 patients, that were scanned for 3D-real IR images at 4 hours after intravenous injection of GBCA as a diagnostic test for endolymphatic hydrops. The patient’s age ranged from 14 to 81 years. Two experienced neuroradiologists evaluated the images to determine whether the GBCA leakage around the cortical veins was positive or negative. Any discrepancies between the two observers were discussed and a consensus was obtained.A Mann–Whitney U test and receiver operating characteristic (ROC) curve analysis were used to compare the positive and the negative group and to set the age cut-off value for the prediction of GBCA leakage.Results:The GBCA leakage around the cortical veins was negative in 35 patients and positive in 155 patients. The average age was 33 ± 11 years in the negative group, and 55 ± 12 years in the positive group (P < 0.01). In the ROC analysis for the age and leakage of the GBCA, an area under the curve was 0.905 and the cut-off age was 37.317 years (sensitivity of 0.942 and specificity of 0.771).Conclusion:Intravenously administered GBCA leaks into the subarachnoid space around the cortical veins in most patients over 37 years of age. However, it should be noted that it can be found occasionally in patients under 37 years of age. 相似文献
4.
Kazunori Aizawa Takeshi Hanaoka Hiroki Kasai Kaoru Kogashi Setsuo Kumazaki Jun Koyama Hiroshi Tsutsui Yoshikazu Yazaki Noboru Watanabe Osamu Kinoshita Uichi Ikeda 《Hypertension research》2006,29(2):123-128
The phosphodiesterase-5 (PDE-5) inhibitor, sildenafil, has been reported to produce sustained pulmonary vasodilatation in patients with pulmonary hypertension (PH). Recently, vardenafil, a more potent and selective PDE-5 inhibitor than sildenafil, has been approved for the treatment of erectile dysfunction. However, the long-term effects of oral vardenafil in patients with PH are unknown. We studied five consecutive patients with PH; one with primary pulmonary hypertension, two with chronic pulmonary thromboembolism, one with Eisenmenger syndrome (ventricular septal defect) and one with secondary pulmonary hypertension after a ventricular septal defect closure operation. In an acute hemodynamic trial, vardenafil (5 mg) significantly decreased both the pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR) with an increase in cardiac output. In a chronic hemodynamic trial, the maintenance dose of vardenafil (10 to 15 mg) for 3 months significantly decreased the PVR, but not the SVR, with a 20.7% reduction of the PVR/ SVR ratio. Plasma brain natriuretic peptide (BNP) levels were also significantly decreased after 3 months. This pilot study demonstrates that long-term oral vardenafil therapy may be a safe and effective treatment for patients with PH. 相似文献
5.
Daisuke Kubota Chizuru Takishima Ken-ichi Ishii Takahiro Kawamura Tomoko Matsumoto Yasuhiro Itsui Eriko Okada Seishin Chin Shinya Oooka Kiichiro Tsuchiya Akihiro Araki Naoya Sakamoto Tatsuya Miyata Takanori Kanai Mamoru Watanabe 《Nihon Shokakibyo Gakkai zasshi》2006,103(9):1044-1049
A 23-year-old man was admitted for treatment of acute exacerbation of ileitis and perianal abscess caused by Crohn's disease. After incision and drainage of the abscess, coupled with antibiotic therapy, 6-mercaptopurine (6-MP) was commenced. His white blood cell (WBC) count on day 12 after initiation of 6-MP was not decreased. However, on day 24 he was re-admitted because of severe myelosuppression (WBC: 300/microl), which was complicated by the recurrence of the perianal abscess. Myelosuppression was prolonged and required the administration of granulocyte colony stimulating factor (G-CSF). G-CSF was continued for 17 days to achieve recovery of his WBC count to a normal level. 相似文献
6.
7.
8.
9.
10.
A Watanabe K Ohizumi M Motomiya K Takeuchi T Yoshida S Ida Y Miura K Nishioka Y Tanno T Takishima 《The Japanese journal of antibiotics》1990,43(8):1392-1401
We evaluated the therapeutic efficacy of miconazole (MCZ, Florid-F inj.), a new antifungal agent for parenteral use, in deep-seated fungal infections of respiratory tract system. A daily dose of 400-1,800 mg of MCZ was given intravenously for 12-38 days (mean: 23.4 days) to 7 patients: 2 patients with pulmonary aspergillosis, 1 patient with bronchial aspergillosis, 1 patient with pulmonary candidiasis and 3 patients with candidemia. One additional patient with pulmonary aspergillosis received three instillations of 20 mg of MCZ into the thoracic cavity. The clinical effects were excellent in 1, good in 4 and poor in 3 patients. The efficacy rate was 100% in 5 cases with respiratory fungal infections but 3 cases with candidemia did not respond well to the treatment. Four strains each of Aspergillus sp. and Candida sp. were identified as causative organisms. Seven of the 8 strains were eradicated by administration of MCZ. Side effects observed were irritation and heat in a leg in 1 patient, hyperlipoidemia in 2 patients and eosinophilia in 1 patient. The adverse reactions disappeared after the completion of the therapy. From the above results, we conclude that MCZ is one of the most useful antifungal agents for parenteral use as a first choice on deep-seated fungal infections in the respiratory tract. 相似文献